Clinico-pathological Characteristics of Prostate Cancer in Korean Men and Nomograms for the Prediction of the Pathological Stage of the Clinically Localized Prostate Cancer: A Multi-institutional Update.
10.4111/kju.2007.48.2.125
- Author:
Cheryn SONG
1
;
Taejin KANG
;
Moo song LEE
;
Jae Y RO
;
Sang Eun LEE
;
Eunsik LEE
;
Han Yong CHOI
;
Deok Hyun HAN
;
Sung Joon HONG
;
Byung Ha CHUNG
;
Choung Soo KIM
;
Hanjong AHN
Author Information
1. Department of Urology, University of Ulsan, Korea. hjahn@amc.seoul.kr
- Publication Type:Original Article
- Keywords:
Prostate neoplasm;
Prostatectomy;
Nomograms
- MeSH:
Biopsy;
Humans;
Lymph Nodes;
Male;
Neoplasm Grading;
Neoplasm Metastasis;
Nomograms*;
Prostate*;
Prostate-Specific Antigen;
Prostatectomy;
Prostatic Neoplasms*;
Seminal Vesicles
- From:Korean Journal of Urology
2007;48(2):125-130
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: In this multi institutional study, the data of 604 men with clinically localized prostate cancer, who underwent radical prostatectomy, with updated nomograms predicting the pathological stage, were analyzed. MATERIALS AND METHODS: Prostate biopsies and prostatectomy specimens from men treated with radical prostatectomy, obtained between 1990 and 2003, were included. The patient distribution with respect to clinical stage, serum prostate-specific antigen (PSA) and biopsy Gleason score, as well as final pathological findings, including organ-confined disease (OCD), extracapsular extension (ECE), seminal vesicle invasion (SVI), and lymph node metastasis (LNM), were analyzed for the construction of nomograms representing the percent probabilities of each respective pathological outcome. RESULTS: The median serum PSA at the time of surgery and biopsy Gleason score were 9.9ng/ml and 7, respectively. The preoperative serum PSA was 4ng/ml or less in 38 (6.3%) patients and the tumor was impalpable in 292 (48.2%) of patients. The biopsy Gleason scores were 7 and 8 or higher in 186 (30.7%) and 169 (27.9%), respectively. Throughout the clinical stages and PSA ranges, the Gleason score was 7 or higher in more than 50% of patients, but 8-10 in 20-30%. The overall OCD, ECE, SVI and LNM rates were 57.1, 27.8, 10.9 and 4.2%, respectively. CONCLISIONS: A significantly high proportion of prostate cancers arising in Korean men exhibited poor differentiation, with Gleason scores of 7 or higher, regardless of the clinical stage or initial serum PSA. Updated nomograms acknowledging such characteristics have been developed, which may aid in the treatment planning of these individuals.
